Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CRIZANLIZUMAB-TMCA: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

63.6%
Female
36.4%
Male

Age Information

The average age of patients reporting adverse events with CRIZANLIZUMAB-TMCA is 29.9 years.

Geographic Distribution

The majority of adverse event reports for CRIZANLIZUMAB-TMCA originate from US.

Report Summary & Outcomes

1,130
Total Reports
1,130
As Primary/Secondary Suspect
37
Deaths Reported
435
Hospitalizations
13
Life-Threatening
26
Disabilities

Reporting Timeline

First adverse event report: 2019. Most recent report: 20250509. View full timeline →

More About CRIZANLIZUMAB-TMCA

CRIZANLIZUMAB-TMCA Full Profile Reports by Year Drug Interactions